News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator     4/20/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted     4/20/2017
A Revealing Conversation With Booming Bay Area Biotech Relypsa (RLYP)’s President Scott Garland     4/20/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies     4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug     4/20/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough     4/20/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
Tech Giant Apple (AAPL) Hires Secret Team of Biomedical Engineers for Treating Diabetes     4/19/2017
FDA Just Rejected Eli Lilly (LLY), Incyte (INCY)'s Rheumatoid Arthritis Drug Baricitinib     4/18/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine     4/18/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study     4/18/2017
Genentech (RHHBY) Shows Off Late-Stage Hemophilia A Data     4/17/2017
3 Biotechs Leading the Pack in The Hepatitis B Space     4/17/2017
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices     4/17/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B     4/14/2017

News from Around the Web
Can Psoriatic Arthritis Lift Gilead (GILD)'s Sinking Ship?     4/20/2017
Can Scientists Rejuvenate An Aging Brain With Young Blood? Stanford University Study     4/20/2017
Entrepreneurs Are Wearing Implants Made For Diabetes In The Pursuit Of 'Human Enhancement'     4/20/2017
New Blood Test Could Treat Non-Small-Cell Lung Cancer Faster, The Journal of Molecular Diagnostics Reveals     4/19/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
How AbbVie (ABBV), Gilead (GILD), Pfizer (PFE) Are All Gaining From Eli Lilly (LLY)'s RA Rejection Pain     4/18/2017
Wearable Sweat Sensor Could Help Diagnose Diseases Like Diabetes, Cystic Fibrosis, Stanford University Study     4/18/2017
Faulty St. Jude Medical (STJ) Devices Were Used in Patients After Recall, Says FDA     4/17/2017
CRISPR Cousin SHERLOCK May Be Able To Track Down Diseases, Broad Institute Scientists Say     4/14/2017
Is Medtronic (MDT)'s Artificial Pancreas The Next Big Thing In Diabetes?     4/14/2017
5 Neuroscience Experts Weigh in on Elon Musk's Mysterious "Neural Lace" Company     4/13/2017
Flugen, Inc. Raises $2M More, Provides Update on Phase I Trial     4/12/2017
Merck & Co. (MRK)'s Diabetes Franchise And The Perils In Proving A Drug's Medical Value     4/12/2017
Alnylam (ALNY)'s Patisiran, Chronicle Of A Death Foretold     4/11/2017
Investors Ready for Brain Cancer Biotech Tocagen's Upcoming IPO This Wednesday     4/11/2017

Press Releases
XBiotech (XBIT) Craters After Disappointing EMA Meeting     4/21/2017
Eiger Biopharma Announces Additional Phase II Clinical Trial Results For Lonafarnib At The International Liver Congress 2017     4/21/2017
Enanta Pharmaceuticals, Inc. Announces Eight Weeks Of Treatment With AbbVie (ABBV)’s Investigational, Pan-Genotypic, Ribavirin-Free HCV Regimen Of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR Rates In Challenging-To-Treat Genotype 3 Chronic HCV Patients     4/21/2017
Gilead (GILD) Presents Data At The International Liver Congress 2017 Supporting The Efficacy And Safety Of Vemlidy In Patients With Chronic Hepatitis B After 96 Weeks, And Also After Switching From Viread     4/21/2017
VBL Therapeutics (VBLX) Announces Positive DSMC Review in Phase III GLOBE Trial Investigating VB-111 in rGBM     4/21/2017
Sunovion Announces Positive Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Children With ADHD     4/21/2017
Gilead (GILD) Presents Proof-Of-Concept Data For GS-0976 In Nonalcoholic Steatohepatitis (NASH) At The International Liver Congress 2017     4/21/2017
Gilead (GILD) Announces Scientific Presentations Demonstrating Efficacy Of Harvoni (Ledipasvir/Sofosbuvir) In Special Patient Populations With HCV Infection     4/21/2017
Tiziana Life Sciences Plc Announces Publication Of Peer-Reviewed Paper From Positive Clinical Trial Of Milciclib In Patients With Refractory Solid Tumours     4/21/2017
Atara Biotherapeutics (ATRA) Announces Positive Interim Results from Ongoing Phase I Trial of the Autologous Version of ATA188 in Patients with Primary and Secondary Progressive Multiple Sclerosis (MS) at the American Academy of Neurology Annual Meeting 2017     4/21/2017
Basilea (BSLN.SW) Announces Agreement With FDA On Special Protocol Assessments For Antibiotic Ceftobiprole Phase III Clinical Studies In Bloodstream And Skin Infections     4/21/2017
BeiGene (BGNE) Announces Initiation Of First Pivotal Study In China Of PD-1 Antibody BGB-A317     4/21/2017
Jounce (JNCE) Initiates Phase II Portion Of ICONIC Study Of JTX-2011 In Patients With Advanced Solid Tumors     4/21/2017
PROMETHERA Biosciences S.A./N.V. Presents Preclinical Data On Novel H2Stem Cell Therapy At EASL International Liver Congress     4/21/2017
Real-World Observational Study In The U.S. Veterans Affairs System Evaluating Use Of Merck & Co. (MRK)’s ZEPATIER (Elbasvir And Grazoprevir) Shows High Sustained Virologic Response Rates In Patients With Chronic Hepatitis C     4/21/2017

//-->